Inside informationEnglish
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 18/03/2026, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 110775_20260318